TNFRSF11B and Huntington disease: Kurnatowska et al. have supported the use of plasma OPG as a marker of the progression of calcification in HD patients [45], and in a study by Ozkok et al., baseline OPG levels were correlated with the progression of CACs at the end of the one-year follow-up.